Stem Cells as a Viable Therapeutic for Cystic fibrosis
For stem cell therapy
to serve as a viable therapeutic for CF the use of heterologous or gene
corrected autologous stem cells which are capable of infusing back into the CF
airways and perform the desired role of Chloride secretion would be required. A
recent study in experimental animal model for CF has reported the usefulness of
MSC as an attractive therapeutic in murine model of CF lung infection and
inflammation. In this model, MSCs were shown to improve gross lung pathology
and decreased the cellular recruitment into the lung, furthermore MSCs shifted
the pulmonary cell predominance from neutrophils to an evenly distributed
predominance of macrophages and neutrophils, thus promoting the resolution of
infection in CF lung, since a predominately neutrophilic inflammation observed
in CF airways is responsible for inflicting a tremendous tissue damage and an
even distribution of macrophages would insure a better response to the
infection through cell mediated immunity.
For stem cell therapy
to function a viable therapeutic for CF the use of heterologous or sequence
corrected autologous stem cells that are capable of infusing back to the CF
airways and perform the specified role of Chloride secretion would be required.
A recent study in experimental animal model for CF has reported the quality of
MSC as an alluring therapeutic in murine model of CF lung infection and
inflammation. In this model, MSCs were shown to improve gross lung pathology
and attenuated the cellular enlisting into the respiratory organ, what is more
MSCs shifted the pneumonic cell predominance from neutrophils to AN equally
distributed predominance of macrophages and neutrophils, so promoting the
resolution of infection in CF respiratory organ, since a predominately
neutrophilic inflammation determined in CF airways is answerable for inflicting
an incredible tissue harm and an excellent distribution of macrophages would
insure an improved response to the infection through cell mediate immunity.
To know more about this
evolving topic let us join the upcoming huge conference i.e International
conference on Cystic Fibrosis which is going to be held during September 20-21,
2018 at Dubai, UAE which will be a definitively informative platform for all,
who are going to attend the conference.
References: Voynow JA, Fischer BM, Zheng S. Proteases and cystic fibrosis. Int J Biochem Cell Biol. 2008;40(6–7):1238–1245.
References: Voynow JA, Fischer BM, Zheng S. Proteases and cystic fibrosis. Int J Biochem Cell Biol. 2008;40(6–7):1238–1245.
Visit:https://cysticfibrosis.conferenceseries.com/
Comments
Post a Comment